Introduction
============

Endovascular aortic repair (EVAR) is a popular treatment for abdominal aortic aneurysms (AAAs) because it is less invasive than open procedures, requires a shorter hospital stay, facilitates a rapid recovery, and is associated with lower postoperative mortality and morbidity \[[@b1-kjtcv-51-180],[@b2-kjtcv-51-180]\]. However, EVAR requires life-long follow-up because reinterventions are often needed due to endoleak, stent migration, and device failure. In addition, aneurysmal progression, in which the aneurysmal sac enlarges, can cause a late rupture \[[@b3-kjtcv-51-180],[@b4-kjtcv-51-180]\].

EVAR can be performed in patients with unfavorable anatomy, but the likelihood of incomplete EVAR is higher in patients with inappropriate geometry in the proximal aortic neck and iliac arteries. In particular, the effectiveness of EVAR in patients with a 'hostile' neck is controversial because of the possibility of type 1a endoleak \[[@b5-kjtcv-51-180]\]. New techniques, such as chimneys and fenestrated or branched EVAR, have been designed, and new devices, such as endoanchors, have been introduced; however, they may not be available in all countries, depending on local circumstances \[[@b6-kjtcv-51-180],[@b7-kjtcv-51-180]\].

Patients with unfavorable iliac anatomy may show incomplete outcomes after undergoing EVAR. In particular, serious adverse events, such as buttock claudication, ischemic colitis, sexual dysfunction, and spinal cord injury, can occur when patients with an iliac aneurysm undergo internal iliac artery (IIA) embolization \[[@b8-kjtcv-51-180],[@b9-kjtcv-51-180]\]. New instruments (e.g., the iliac branched device) and new methods (e.g., the sandwich technique) have been developed. However, procedures using these innovations are still technically demanding and cannot exclude the possibility of endoleak or guarantee long-term patency \[[@b10-kjtcv-51-180]\].

This study examined the short-term outcomes of EVAR in patients with a hostile neck and unfavorable iliac anatomy, as well as the risk factors for aneurysmal sac enlargement after EVAR.

Methods
=======

1) Study design and patient population
--------------------------------------

This was as ingle-center, retrospective, observational study based on a review of patients' medical records. A total of 51 patients with infrarenal AAA visited Dongguk University Ilsan Hospital from January 2012 to December 2017. Ten of them underwent open surgery and 41 underwent EVAR. Two patients with a ruptured AAA and 1 with an infected AAA were excluded. In total, 38 patients were enrolled in this study.

This study was approved by the Institutional Review Board of Dongguk University Ilsan Hospital. Individual patient consent was waived because this study did not interfere with patient treatment, and the database was designed so that individual patients could not be identified.

2) Variables of interest
------------------------

The patients' demographics (age and gender), risk factors (hypertension, diabetes mellitus, coronary artery disease, history of a cerebrovascular accident, and chronic kidney disease), preoperative medications (antiplatelet agents and statins), preoperative computed tomographic findings (maximum aneurysm diameter, proximal neck abnormalities \[i.e., length, angulation, and the presence and shape of a thrombus\], and iliac artery abnormalities \[i.e., length and diameter\]) were examined. The clinical course (mortality and morbidity, intensive care unit \[ICU\] and hospital stay, and incidence of post-implantation syndrome) and follow-up radiologic findings (aneurysmal sac growth and endoleak) were also recorded for each patient.

3) Perioperative procedure
--------------------------

EVAR was performed in all patients under general anesthesia. Prophylactic antibiotics (first-generation cephalosporin) were administered 30 minutes before the incision, and heparin (body weight \[kg\]×100 units) was administered intravenously. With respect to the approach, a bilateral or unilateral inguinal incision was performed without a preclosing device. After exposing the femoral artery, a purse-string suture was performed using 5-0 Prolene, and the device was engaged using the Seldinger technique. If an iliac aneurysm was observed, concomitant IIA embolization was performed using detachable coils. All patients were hydrated with normal saline from 1 day prior to surgery to the day after surgery, and 1,200 mg of acetylcysteine was administered to patients with chronic kidney disease who did not undergo hemodialysis from 1 day before surgery to the day after surgery. Aspirin (100 mg) was administered starting at 1 day post-surgery. A single surgeon performed the surgical procedures.

4) Imaging review
-----------------

Computed tomographic angiography (CTA) with a 2-mm thickness was performed in all patients before surgery. The presence of a hostile neck and/or unfavorable iliac anatomy was reviewed on preoperative CTA. A hostile neck was considered present if any of the following features were present: (1) short neck: a distance between the most caudal renal artery and the aneurysmal sac of less than 10 mm; (2) angulated neck: an aortic angle of 60° or more within 30 mm from the most caudal renal artery; (3) neck thrombus: a thrombus of more than 50% of the cross-sectional area was observed in the proximal neck; or (4) conical shape: a diameter of more than 2 mm with gradual neck dilation within the first 10 mm distal to the most caudal renal artery. Unfavorable iliac anatomy was defined as the presence of either of the following features: (1) iliac aneurysm: a common iliac artery (CIA) diameter greater than 30 mm; or (2) a short CIA: a CIA length less than 15 mm. With respect to aneurysmal growth, the patients were classified according to whether they showed a lower maximal diameter on the last postoperative follow-up CTA in comparison to the preoperative CTA findings. The maximal diameter was measured as the largest minor axis of the elliptical aneurysm in the axial image.

5) Statistical analysis
-----------------------

Continuous variables are reported as mean±standard deviation, and dichotomous variables are reported as counts and percentages. For continuous variables, the Student t-test was conducted if the variable was normally distributed, whereas the Mann-Whitney U-test was used for non-normally distributed variables. The chi-square test was used for categorical variables. To examine the risk factors for aneurysmal changes, multivariate analysis was performed using a stepwise logistic regression model. IBM SPSS for Windows ver. 19.0 (IBM Corp., Armonk, NY, USA) was used for all statistical analyses, and p-values less than 0.05 were considered to indicate statistical significance.

Results
=======

[Table 1](#t1-kjtcv-51-180){ref-type="table"} lists the patients' characteristics and their perioperative clinical data. No cases of perioperative mortality or major complications occurred. Type 2 and 1a endoleaks were noted in 6 patients and 1 patient, respectively. Open conversion was not performed, and limb occlusion occurred in 2 patients after surgery; a thrombectomy and stent insertion were performed on the next day. The maximal aortic diameter, mean length of stay in the ICU, and postoperative length of stay in the hospital were 56.7±9.1 mm, 22.3±13.4 hours, and 9.6±11.9 days, respectively. Endurant (Medtronic Vascular, Santa Rosa, CA, USA), AFX2 (Endologix Inc., Irvine, CA, USA), and Excluder (WL Gore and Associates, Flagstaff, AZ, USA) were used as the endograft for 34 patients, 3 patients, and 1 patient, respectively.

A hostile neck was observed in 13 patients, as shown in [Table 2](#t2-kjtcv-51-180){ref-type="table"}. Five patients showed an angulation of 60° or more, and 3 patients each had a short neck, large amount of mural thrombus, and a conical shape. One patient showed a 9-mm short neck with a severe angulation of 70°, and a type 1a endoleak occurred in that patient.

[Table 3](#t3-kjtcv-51-180){ref-type="table"} compares the results of the patients with and without a hostile neck. No significant difference was observed between the 2 groups in terms of the patients' prior history or maximal diameter, and there were no differences in the incidence of endoleak or sac growth. No significant difference in the postoperative clinical course was observed between the 2 groups.

Unfavorable iliac anatomy was defined based on 2 criteria. As shown in [Table 4](#t4-kjtcv-51-180){ref-type="table"}, 11 patients had an iliac aneurysm and 4 patients had a short CIA. IIA embolization was performed in 8 patients, unilateral embolization in 7 patients, and bilateral embolization with a 2-week interval in 1 patient. Embolization was not performed in patients with a IIA occlusion or those who were determined to have a spontaneous IIA occlusion due to a deployed stent-graft.

[Table 5](#t5-kjtcv-51-180){ref-type="table"} compares the results of the 2 groups defined according to iliac anatomy. No case of type1b endoleak was observed. More males showed unfavorable iliac anatomy, but this tendency was not statistically significant (p=0.06). Prior medical history and the incidence of endoleak were similar in the 2 groups, whereas a significant difference was observed in the growth of the aneurysmal sac (p=0.04). No significant difference was observed in the length of the postoperative ICU stay or the length of the hospital stay.

Risk factors for aneurysmal sac growth were analyzed, as listed in [Table 6](#t6-kjtcv-51-180){ref-type="table"}. Multivariate analysis revealed unfavorable iliac anatomy to be the only risk factor (odds ratio, 7.66; 95% confidence interval, 1.37--42.82; p=0.02). The interval between surgery and the last follow-up CTA was 11.3±13.5 months.

Discussion
==========

Since the first report of EVAR by Parodi et al. \[[@b11-kjtcv-51-180]\] in 1991, this technique has become a popular first-line treatment of AAA. In many centers, the trend to perform EVAR rather than open surgery has increased, with various attempts to carry out interventions beyond the instructions for use (IFU) suggested by the manufacturers. In most cases, an aortic neck \>15 mm in length, \<28 mm in diameter, and with an angulation \<60° are suggested in the IFU, and a distal landing zone \>15 mm in length and \<22 mm in diameter is recommended. Nonetheless, a variety of techniques and devices have been developed because many patients diagnosed with AAA do not fit these criteria.

The neck anatomy of an aneurysm is the most critical variable for performing EVAR successfully. Numerous studies have shown that a hostile neck anatomy leads to poor outcomes \[[@b12-kjtcv-51-180]\]. In these studies, a short neck and an angulated neck were risk factors for type 1a endoleak, and these patients showed a poor prognosis. Nevertheless, Schanzer et al. \[[@b13-kjtcv-51-180]\] reported that many physicians and interventionists performed EVAR beyond IFU in the real world.

Many techniques have been designed to overcome a hostile neck. Typical examples include chimney EVAR (ChEVAR) and fenestrated EVAR (fEVAR). Antoniou et al. \[[@b14-kjtcv-51-180]\] reported a 91% technical success rate with a 13% incidence of type 1a endoleak after ChEVAR. Moulakakis et al. \[[@b15-kjtcv-51-180]\] reported a 100% primary technical success rate with a 14% incidence of type 1 endoleak. They claimed that ChEVAR could be a treatment option for high-risk patients. Tambyraja et al. \[[@b16-kjtcv-51-180]\] reported the outcomes of 29 patients who underwent fEVAR, demonstrating no 30-day mortality but a 38% rate of reintervention. New devices, such as endoanchors and endostaples, have been introduced, but these products cannot be used in all countries due to variations in reimbursement guidelines. Currently, these products can be used in Korea to a very limited extent.

In this study, cases of a hostile neck were managed only by traditional methods, such as the insertion of an additional cuff or repetitive ballooning. Although no patient underwent ChEVAR or fEVAR, and a balloon-expandable stent was not used in any patient, there was only 1 case of type 1a endoleak. This reflects the fact that open surgery was performed on patients who were young or had a juxtarenal AAA with a hostile neck, as mentioned previously. Four patients with a hostile neck underwent open surgery during the same period. In our hospital, open surgery was performed selectively in patients with a hostile neck, particularly when a short and angulated neck was found simultaneously. EVAR was preferred if the proximal neck was short but the angulation was not severe, or if the angulation was severe, but the neck was long. In this study, 1 patient who underwent EVAR had a short and angulated neck but could not undergo open surgery because of a co-morbidity and old age.

An iliac aneurysm has been reported to occur in approximately 20% of patients who undergo AAA repair and in up to 40% of cases of iliac artery ectasia \[[@b17-kjtcv-51-180]\]. In the IFU of most manufacturers, the indications of EVAR related to the iliac artery include an iliac diameter of no more than 22 mm and a length no less than 15 mm. Because the risk of rupture is increased if the maximal diameter is more than 35 mm in an isolated CIA aneurysm, the aneurysm was sometimes excluded after sacrificing the IIA. Internal iliac embolization is a relatively common procedure in patients with a short CIA. In such cases, complications, such as buttock claudication, ischemic colitis, erectile dysfunction, and spinal cord injury, have been reported \[[@b8-kjtcv-51-180],[@b9-kjtcv-51-180]\]. Therefore, iliac branched devices have been developed for commercialization, but they are unavailable in Korea. Currently, chimney, snorkel, and sandwich techniques are available in Korea. DeRubertis et al. \[[@b18-kjtcv-51-180]\] reported that the patency of the external iliac artery and IIA was 95% and 88%, respectively, among 22 patients who underwent the sandwich technique. In addition, they reported relatively favorable outcomes, with 1 case of type 1b endoleak and 3 cases of type 2 endoleak without any buttock claudication in the surgical areas.

In the present study, 8 out of the 15 patients who had unfavorable iliac anatomy underwent iliac artery embolization, and no procedure was performed for revascularization, such as sandwich or chimney techniques. Type 1b endoleak did not occur and no other severe complications, such as ischemic colitis, erectile dysfunction, and spinal cord injury, were observed. Buttock claudication was observed in 3 patients, and the symptoms disappeared during follow-up in 1 of these patients. A bilateral short CIA was observed in 1 patient who underwent open surgery with an abdominal aortic replacement.

The short-term outcomes of EVAR were favorable, but the long-term outcomes are still uncertain. The fundamental reason for this is that EVAR leaves the aneurysmal sac in place so that the blood supply can be sustained within this sac, which can be enlarged. This can cause a late rupture, and this possibility requires life-long follow up. In the authors' hospital, postoperative CTA is performed before discharge in all patients, and CTA is repeated 3 months after surgery in patients with endoleak. In patients without endoleak, CTA is performed 6 months and 1 year after surgery. In addition, if sac enlargement is suspected, CTA is performed every 6 months thereafter; otherwise, CTA is performed annually. Schanzer et al. \[[@b13-kjtcv-51-180]\], who examined the outcomes of a 5-year follow-up period, warned that sac enlargement occurred in 41% of patients who underwent EVAR. In other studies, an 8%--10% incidence of late sac enlargement after 3 years of follow-up was reported \[[@b19-kjtcv-51-180]\].

The most common risk factor for aneurysmal sac growth is endoleak. Types 1 and 3 endoleak require immediate reintervention because they cause late sac enlargement. Type 2 endoleak shows mostly benign features, although a report of persistent type 2 endoleak causing aneurysm related-death has been published \[[@b20-kjtcv-51-180]\]. Nevertheless, the main causes of late sac enlargement are types 1 and 3 endoleak, which are closely related to unfavorable anatomy.

In this study, endoleak occurred in 7 patients, but it was not determined to be an inhibitory factor for sac shrinkage. This may result from the fact that we only analyzed short-term outcomes, which is the major limitation of this study. Additional limitations of this study include the fact that this was a retrospective study, and a relatively small number of patients were enrolled. Finally, the ambiguity of the operative indications for open surgery and EVAR may be another limitation. Therefore, a study with a long-term follow-up and large patient sample is required to determine the safety of EVAR in patients with unfavorable aortoiliac anatomy.

In conclusion, favorable short-term outcomes can be anticipated for EVAR performed in patients with unfavorable aortic anatomy. However, caution is needed when treating patients with an iliac aneurysm or short CIA, because these were revealed to be risk factors for inhibited aneurysmal sac shrinkage.
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###### 

Patients' baseline characteristics and perioperative clinical data (n=38)

  Characteristic                  Value
  ------------------------------- -----------
  Age (yr)                        75.6±8.5
  Male gender                     28 (74)
  Hypertension                    28 (74)
  Diabetes mellitus               7 (18)
  Coronary artery disease         8 (21)
  Cerebrovascular accident        9 (24)
  Chronic kidney disease          3 (8)
  Antiplatelet agent use          22 (58)
  Statin use                      18 (47)
  Diameter of aneurysm (mm)       56.7±9.1
  Intensive care unit stay (hr)   22.3±13.4
  Hospital stay (day)             9.6±11.9

Values are presented as mean±standard deviation or number of patients (%).

###### 

Categories of hostile neck (n=13)

  Type                  No. of patients (%)
  --------------------- ---------------------
  Neck length \<10 mm   3 (23)
  Angulation \>60°      5 (38)
  Thrombus \>50%        3 (23)
  Conical shape         3 (23)

###### 

Comparison of the patients' characteristics and clinical data between those with and without hostile neck

  Characteristic                 Hostile neck (n=13)   Non-hostile neck (n=25)   p-value
  ------------------------------ --------------------- ------------------------- ---------
  Age (yr)                       73.9±7.4              76.4±9.1                  0.40
  Male gender                    11 (85)               17 (68)                   0.44
  Hypertension                   10 (77)               18 (72)                   1.00
  Diabetes mellitus              3 (23)                4 (16)                    0.67
  Coronary artery disease        3 (23)                5 (20)                    1.00
  Cerebrovascular accident       4 (31)                5 (20)                    0.69
  Chronic kidney disease         1 (8)                 2 (8)                     1.00
  Antiplatelet agent use         8 (62)                14 (56)                   0.74
  Statin use                     7 (54)                11 (44)                   0.56
  Diameter of aneurysm (mm)      58.9±8.8              55.5±9.2                  0.27
  Post-implantation syndrome     2 (15)                6 (24)                    0.69
  Endoleak                       2 (15)                5 (20)                    1.00
  Unchanged or larger sac        5 (38)                10 (40)                   0.93
  Intensivecare unit stay (hr)   20.1±15.8             23.5±12.3                 0.47
  Hospital stay (day)            8.6±4.5               10.1±14.4                 0.72

Values are presented as mean±standard deviation or number of patients (%).

###### 

Categories of unfavorable iliac anatomy (n=15)

  Type                                No. of patients (%)
  ----------------------------------- ---------------------
  Iliac aneurysm \>30 mm              11 (73)
  Short common iliac artery \<15 mm   4 (27)
  Coil embolization                   8 (53)

###### 

Comparison of the patients' characteristics and clinical data between those with and without unfavorable iliac anatomy

  Characteristic                  Unfavorable iliac anatomy (n=15)   Favorable iliac anatomy (n=23)   p-value
  ------------------------------- ---------------------------------- -------------------------------- ---------
  Age (yr)                        75.3±8.4                           75.7±8.7                         0.87
  Male gender                     14 (94)                            14 (61)                          0.06
  Hypertension                    11 (73)                            17 (74)                          1.00
  Diabetes mellitus               2 (13)                             5 (22)                           0.68
  Coronary artery disease         3 (20)                             5 (22)                           1.00
  Cerebrovascular accident        3 (20)                             6 (26)                           1.00
  Chronic kidney disease          1 (7)                              2 (9)                            1.00
  Antiplatelet agent use          6 (40)                             16 (70)                          0.07
  Statin use                      5 (33)                             13 (57)                          0.16
  Diameter of aneurysm (mm)       56.5±9.3                           56.8±9.2                         0.92
  Post-implantation syndrome      3 (20)                             5 (22)                           1.00
  Endoleak                        3 (20)                             4 (17)                           1.00
  Unchanged or increased sac      9 (60)                             6 (26)                           0.04
  Intensive care unit stay (hr)   20.4±6.2                           23.6±16.6                        0.49
  Hospital stay (day)             8.5±6.2                            10.3±14.6                        0.67

Values are presented as mean±standard deviation or number of patients (%).

###### 

Multivariate analysis of the risk factors for sac enlargement after endovascular aortic repair

  Predictor                    Univariate analysis   Multivariate analysis   
  ---------------------------- --------------------- ----------------------- --------------------
  Age                          0.81                                          
                                                                             
  Male gender                  0.26                  0.51                    1.90 (0.28--12.84)
                                                                             
  Hypertension                 0.26                  0.24                    3.05 (0.48--19.58)
                                                                             
  Diabetes mellitus            0.68                                          
                                                                             
  Coronary artery disease      0.69                                          
                                                                             
  Cerebrovascular accident     0.44                                          
                                                                             
  Chronic kidney disease       0.55                                          
                                                                             
  Antiplatelet agent use       0.38                                          
                                                                             
  Statinuse                    0.21                  0.07                    4.83 (0.87--26.73)
                                                                             
  Diameter of aneurysm         0.99                                          
                                                                             
  Hostile neck                 0.93                                          
                                                                             
  Unfavorable iliac anatomy    0.04                  0.02                    7.66 (1.37--42.82)
                                                                             
  Post-implantation syndrome   0.44                                          
                                                                             
  Endoleak                     0.40                  0.35                    2.69 (0.34--21.49)
